Teva Pharmaceutical Industries Limited
- TEVA
- NYSE
- Drug Manufacturers - Specialty & Generic
- Generic Pharmaceuticals
- Specialty/Biopharmaceuticals
$41.31
Today −0.46%Quote Oct 19, 2026, 08:00 PM UTC
+5.98%over the last month
Max drawdown −3.3%From 1-month high −0.5%3 months +31.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Teva Pharmaceutical Industries
Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets.
Where the money comes from
Q1 2026 revenue $3.98B
- Product$3.39B85.1%
- Distribution Service$396.0M9.9%
- Product and Service, Other$157.0M3.9%
- License$39.0M1.0%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
Employees
32,008
Market value
$48.14B
Quote Oct 19
Floor
$40.78
1.3% below price
Resistance
$41.32
0.0% above price
Price vs analyst targets
46 analysts
Lowest target
$44.00Highest target
$50.00
$44.00Highest target
$50.00
- Price $41.31
- Average target $47.33
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 15% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TEVAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free